Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants - Related Studies

Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants (BMT CTN 0101)

This study has been completed.

Study NCT00075803. Last updated on August 20, 2008. Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lymphoma
		Infection
		Leukemia

2	Additional conditions recognized in this trial
		Communicable Diseases
		Mycoses

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		Fluconazole
		Voriconazole

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		National Heart, Lung, and Blood Institute (NHLBI)
		Blood and Marrow Transplant Clinical Trials Network
		National Cancer Institute (NCI)